Content about Tyrosine kinase inhibitors

June 4, 2012
Bayer gastrointestinal cancer drug extends progression-free survival in trial

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

May 16, 2012
Results from phase-3 trial of Pfizer cancer drug disappoint

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 3, 2012
Walgreens Specialty fortifies oncology service with six new oral therapies

Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.

March 30, 2012
Genentech announces results of cancer drug trial

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 16, 2012
Patients taking oral cancer drugs may risk drug interactions, study finds

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

February 17, 2012
Pfizer cancer drug hits BioPlus' shelves

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

February 1, 2012
FDA approves new indication for Novartis' Gleevec

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

January 27, 2012
FDA approves Pfizer's Inlyta for advanced kidney cancer

The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

December 20, 2011
Apothecary Shops distributes GlowCap in pilot program

Specialty pharmacy provider The Apothecary Shops is encouraging medication adherence with a cap for pill containers that cues patients with lights and sounds, the company said.

December 8, 2011
FDA panel votes in favor of Pfizer kidney cancer drug

A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

May 23, 2011
Sutent OKed as pancreatic NET treatment

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

December 9, 2010
Trial data of investigational lung cancer treatment said to extend survival by more than four months

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

November 18, 2010
Pfizer on kidney cancer drug: Extends lives of patients

Pfizer got promising results from a late-stage clinical trial of a cancer treatment, the drug...

October 27, 2010
FDA OKs expanded use of Sprycel

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

September 27, 2010
Pfizer abandons Sutent trial

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

September 22, 2010
FDA accepts approval application for AstraZeneca's vandetanib

The Food and Drug Administration has accepted AstraZeneca’s regulatory application for an investigational cancer drug,...

September 16, 2010
BI commences late-stage clinical trial for breast cancer treatment

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

August 26, 2010
Pfizer reports mixed results in late-stage clinical trial

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

July 18, 2010
Reporters Notebook

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

July 11, 2010
Sprycel receives priority review from FDA

A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...

June 17, 2010
Novartis’ Tasigna receives nod from FDA

The Food and Drug Administration has approved a drug as an early treatment for a...

March 11, 2010
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

February 18, 2010
Novartis' Tasigna receives priority review from FDA

The Food and Drug Administration will shorten its review time of a Novartis drug under...

January 18, 2010
FDA extends review of lung cancer treatment

The Food and Drug Administration has extended its review period for a lung cancer drug...

© 2013 Drug Store News. All Rights Reserved.